Ellipses Pharma

Ellipses Pharma is a clinical-stage oncology drug development company that in-licenses cancer drug assets from academia and industry, advances them through clinical trials using a continuous funding model, and out-licenses at value-inflection points.

Its pipeline spans small molecule kinase inhibitors, selective receptor modulators, monoclonal antibodies, and antibody-drug conjugates across multiple solid tumour and haematological malignancy indications.